Management of chronic HBV-HDV patients chronic HBV-HDV infection

Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some li...

Descripción completa

Detalles Bibliográficos
Autores: Buti, Maria|||0000-0002-0732-3078, Gonzalez, Alexia, Riveiro Barciela, Mar|||0000-0001-9309-2052, Bourliere, Marc
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:dnet:uabarcelona_::7daa7c77b34a6e2025f1960e7cb60dbd
Acceso en línea:https://ddd.uab.cat/record/328311
https://dx.doi.org/urn:doi:10.1002/ueg2.12494
Access Level:acceso abierto
Palabra clave:Buleviritide
chronic HBV-HDV infection
hepatitis B virus
hepatitis D virus
Interferon alpha
Lonafarnib
id ES_dcfaf497dc547d818650fb356e4e776a
oai_identifier_str oai:dnet:uabarcelona_::7daa7c77b34a6e2025f1960e7cb60dbd
network_acronym_str ES
network_name_str España
repository_id_str
spelling Management of chronic HBV-HDV patients chronic HBV-HDV infectionA review on new management optionsButi, Maria|||0000-0002-0732-3078Gonzalez, AlexiaRiveiro Barciela, Mar|||0000-0001-9309-2052Bourliere, MarcBuleviritidechronic HBV-HDV infectionhepatitis B virushepatitis D virusInterferon alphaLonafarnibHepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some light for patients with Chronic Hepatitis D, although important gaps regarding its use in therapy as well as about the epidemiology and diagnosis of the disease need to be addressed. 22023-01-0120232023-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/328311https://dx.doi.org/urn:doi:10.1002/ueg2.12494reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:dnet:uabarcelona_::7daa7c77b34a6e2025f1960e7cb60dbd2026-06-06T12:50:31Z
dc.title.none.fl_str_mv Management of chronic HBV-HDV patients chronic HBV-HDV infection
A review on new management options
title Management of chronic HBV-HDV patients chronic HBV-HDV infection
spellingShingle Management of chronic HBV-HDV patients chronic HBV-HDV infection
Buti, Maria|||0000-0002-0732-3078
Buleviritide
chronic HBV-HDV infection
hepatitis B virus
hepatitis D virus
Interferon alpha
Lonafarnib
title_short Management of chronic HBV-HDV patients chronic HBV-HDV infection
title_full Management of chronic HBV-HDV patients chronic HBV-HDV infection
title_fullStr Management of chronic HBV-HDV patients chronic HBV-HDV infection
title_full_unstemmed Management of chronic HBV-HDV patients chronic HBV-HDV infection
title_sort Management of chronic HBV-HDV patients chronic HBV-HDV infection
dc.creator.none.fl_str_mv Buti, Maria|||0000-0002-0732-3078
Gonzalez, Alexia
Riveiro Barciela, Mar|||0000-0001-9309-2052
Bourliere, Marc
author Buti, Maria|||0000-0002-0732-3078
author_facet Buti, Maria|||0000-0002-0732-3078
Gonzalez, Alexia
Riveiro Barciela, Mar|||0000-0001-9309-2052
Bourliere, Marc
author_role author
author2 Gonzalez, Alexia
Riveiro Barciela, Mar|||0000-0001-9309-2052
Bourliere, Marc
author2_role author
author
author
dc.subject.none.fl_str_mv Buleviritide
chronic HBV-HDV infection
hepatitis B virus
hepatitis D virus
Interferon alpha
Lonafarnib
topic Buleviritide
chronic HBV-HDV infection
hepatitis B virus
hepatitis D virus
Interferon alpha
Lonafarnib
description Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some light for patients with Chronic Hepatitis D, although important gaps regarding its use in therapy as well as about the epidemiology and diagnosis of the disease need to be addressed.
publishDate 2023
dc.date.none.fl_str_mv 2
2023-01-01
2023
2023-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/328311
https://dx.doi.org/urn:doi:10.1002/ueg2.12494
url https://ddd.uab.cat/record/328311
https://dx.doi.org/urn:doi:10.1002/ueg2.12494
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421818258915328
score 15,812455

Similares en LA Referencia